The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021
US$ 3,000.00
Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 70 (HSP70) targeted pipel...
April 2021
45 pages
Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021
US$ 3,000.00
Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 90 (HSP90) targeted pipel...
April 2021
80 pages
Hemagglutinin 5 (H5) - Drugs in Development, 2021
US$ 3,000.00
Hemagglutinin 5 (H5) - Drugs in Development, 2021 SUMMARY Hemagglutinin 5 (H5) - Drugs in Development, 2021 provides in depth analysis on Hemagglutinin 5 (H5) targeted pipeline therapeutics. The repor...
April 2021
30 pages
Hematological Tumor (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Hematological Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Hematological Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Hematological Tumor pipeline landscape. The...
April 2021
425 pages
Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021
US$ 3,000.00
Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 SUMMARY Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 provides in depth analysis on Heme Polymerase (EC 2.0.0.0) targeted pipeline...
April 2021
30 pages
High-Grade Glioma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
High-Grade Glioma (Oncology) - Drugs in Development, 2021 SUMMARY High-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape. The report...
April 2021
130 pages
Histamine H1 Receptor (HRH1) - Drugs in Development, 2021
US$ 3,000.00
Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 SUMMARY Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 provides in depth analysis on Histamine H1 Receptor (HRH1) targeted pipeline...
April 2021
80 pages
HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021
US$ 3,000.00
HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 SUMMARY HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 provides in depth analysis on HIV 1 Integrase (EC 2.7.7.) targeted pipeline th...
April 2021
45 pages
HSV-1 (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
HSV-1 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-1 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-1 pipeline landscape. The report provides compre...
April 2021
30 pages
HSV-2 (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
HSV-2 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-2 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-2 pipeline landscape. The report provides compre...
April 2021
35 pages
